These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6587212)

  • 41. Partial ileal bypass for hypercholesterolaemia.
    Schwartz MZ
    Lancet; 1982 Jan; 1(8263):110. PubMed ID: 6119476
    [No Abstract]   [Full Text] [Related]  

  • 42. [Effect of cholestyramine on the clinico-biochemical indices of ischemic heart disease patients].
    Serkova VK; Mikunis RI
    Vrach Delo; 1987 Jul; (7):14-7. PubMed ID: 3630106
    [No Abstract]   [Full Text] [Related]  

  • 43. Does cholestyramine interfere with cyclosporine absorption? A prospective study in renal transplant patients.
    Jensen RA; Lal SM; Diaz-Arias A; James-Kracke M; Van Stone JC; Ross G
    ASAIO J; 1995; 41(3):M704-6. PubMed ID: 8573896
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Urethral calculi caused by cholestyramine.
    Courtney SP; Wightman JA
    Br J Urol; 1991 Dec; 68(6):654. PubMed ID: 1773297
    [No Abstract]   [Full Text] [Related]  

  • 45. Letter: Portacaval shunt in familial hypercholesterolaemia.
    Mitchell S; Levy RI
    Lancet; 1974 Nov; 2(7891):1263-4. PubMed ID: 4139495
    [No Abstract]   [Full Text] [Related]  

  • 46. Cholesterol-lowering drugs. Some drugs with demonstrated efficacy but different benefits in primary and secondary prevention.
    Prescrire Int; 1999 Aug; 8(42):116-20. PubMed ID: 11503831
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Liver disease and pregnancy. A pregnancy complicated by icterus and pruritus, treated with cholestyramine resin].
    Briët JW; Eskes TK; Kamminga GA
    Ned Tijdschr Verloskd Gynaecol; 1969 Dec; 69(6):475-87. PubMed ID: 5354520
    [No Abstract]   [Full Text] [Related]  

  • 48. [Combination therapy of hypercholesterolemia].
    Vanhanen H; Gylling H; Miettinen TA
    Duodecim; 2002; 118(19):1967-73. PubMed ID: 12462803
    [No Abstract]   [Full Text] [Related]  

  • 49. [Cholesterol consensus in The Netherlands].
    Donkerlo TW
    Ned Tijdschr Geneeskd; 1987 Oct; 131(43):1928-9. PubMed ID: 3683611
    [No Abstract]   [Full Text] [Related]  

  • 50. Metabolism of apolipoprotein B in primary moderate hypercholesterolaemia: effects of acipimox and cholestyramine therapy.
    Gaw A; Packard CJ; Lindsay GM; Collins SM; Lorimer AR; Shepherd J
    Eur J Med Res; 1995 Oct; 1(1):38-48. PubMed ID: 9392692
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Malabsorption of thyroid hormone with cholestyramine administration.
    Rosenberg R
    Conn Med; 1994 Feb; 58(2):109. PubMed ID: 8004946
    [No Abstract]   [Full Text] [Related]  

  • 52. [Disorders of lipid metabolism--diagnosis and therapy in general practice. 4: Therapy of hypercholesterolemia--drug treatment].
    Richter WO
    Fortschr Med; 1996 May; 114(14):177-8. PubMed ID: 8707237
    [No Abstract]   [Full Text] [Related]  

  • 53. Plasma cholesteryl ester transfer protein is lowered by treatment of hypercholesterolemia with cholestyramine.
    Carrilho AJ; Medina WL; Nakandakare ER; Quintão EC
    Clin Pharmacol Ther; 1997 Jul; 62(1):82-8. PubMed ID: 9246022
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fenofibrate and cholestyramine in type II hyperlipoproteinaemia.
    Lehtonen A; Viikari J
    Artery; 1982; 10(5):353-67. PubMed ID: 7181678
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of cholesterol reduction with cholestyramine on renal function.
    Kshirsagar AV; Shoham DA; Bang H; Hogan SL; Simpson RJ; Colindres RE
    Am J Kidney Dis; 2005 Nov; 46(5):812-9. PubMed ID: 16253720
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preventing myocardial infarction: cholestyramine (Questran) and other hypolipidemics.
    Pepper GA
    Nurse Pract; 1986 Mar; 11(3):84, 86, 88. PubMed ID: 3951771
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Choice of cholesterol-lowering drugs.
    Med Lett Drugs Ther; 1993 Mar; 35(891):19-22. PubMed ID: 8433674
    [No Abstract]   [Full Text] [Related]  

  • 58. Prevention of coronary heart disease with pravastatin.
    Davis DR
    N Engl J Med; 1996 May; 334(20):1334; author reply 1335. PubMed ID: 8609958
    [No Abstract]   [Full Text] [Related]  

  • 59. Effects of variable doses and formulations of cholestyramine on elevated serum low-density lipoprotein cholesterol.
    Fletcher GF; Fletcher BJ; Whitner JT; Staggers J; Almon L
    Am J Cardiol; 1995 Apr; 75(10):738-9. PubMed ID: 7900676
    [No Abstract]   [Full Text] [Related]  

  • 60. [New markers of atherogenic risk: hemorrheological profile in children and adolescents with familial hypercholesterolemia].
    Dalmau Serra J; Vayá Montaña A; Martínez Silvestre M; Blesa Baviera LC; Aznar Lucea J
    An Esp Pediatr; 1996 Oct; 45(4):393-7. PubMed ID: 9005727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.